scholarly journals Modern Investigation toward Shari’ah Compliance: Squatting Uroflowmetry

2018 ◽  
Vol 17 (2) ◽  
Author(s):  
Muhd Zaki Azre Redzuan ◽  
Mohd Nazli Kamarulzaman ◽  
Hamid Ghazali
Keyword(s):  
Flow Rate ◽  
Maximum Flow ◽  
Daily Practice ◽  
Standing Position ◽  
Average Flow Rate ◽  
Urinary Tract Symptoms ◽  
Significant Difference ◽  
Urology Clinic ◽  
Clinic Hospital ◽  
Lower Urinary

INTRODUCTION: Standard uroflowmetry is performed in a standing position and it is an important investigation for those who are suspected of having lower urinary tract symptoms such as benign prostatic hyperplasia (BPH). Effects of changing positions during uroflowmetry have also been investigated previously but mixed conclusions were made. For Muslims, voiding in squatting position is encouraged as part as daily practice. This is mainly due to cleanliness reason and many Hadiths have emphasised about it. Objective: The aim of this study is to compare uroflowmetry findings between squatting and standing positions amongst BPH patients attending urology clinic Hospital Tengku Ampuan Afzan (HTAA).  Methods: This is a cross section observational study carried out from March 2015 to December 2015. The maximum flow rate, average flow rate, voiding volume, total voiding time and post-voiding residual volume were measured and recorded. Results: The results were then compared and analysed. 64.2% of patients were non-Muslims. 78.0% of the patients voiding habit were standing and 12.2% squatting position at home. The average International Prostate Symptom Score (IPSS) was 12.07 and 63.4% of them were in moderate group disease. Post void residual (PVR) volume showed a reduction in squatting position (p<0.05). Otherwise there was no significant difference seen in other parameters. Conclusion: This study showed that voiding in squatting position, which is shari’ah compliant is not inferior compare to standard uroflowmetry. Therefore Muslim patients should be given the option to perform uroflowmetry in a squatting position if available. This may yield better results.

scholarly journals The effect of alpha blockers on uroflowmetric parameters in different voiding positions

2013 ◽  
Vol 7 (5-6) ◽  
pp. 329
Author(s):  
Gokhan Koc ◽  
Yuksel Yilmaz ◽  
Sitki Un ◽  
Kaan Akbay ◽  
Firat Akdeniz
Keyword(s):  
Flow Rate ◽  
Urine Volume ◽  
Maximum Flow ◽  
Standing Position ◽  
Prostatic Hyperplasia ◽  
Sitting Position ◽  
Average Flow Rate ◽  
Symptomatic Benign Prostatic Hyperplasia ◽  
Transabdominal Ultrasonography ◽  
Alpha Blockers

Introduction: We assessed the effect of different voiding positionson uroflowmetric parameters and post-void residual (PVR)urine volume in symptomatic benign prostatic hyperplasia (BPH)patients. We also evaluated the effect of alpha blockers on PVR indifferent voiding positions.Methods: The study was performed with 110 BPH patients over 50years old. In total, 4 uroflowmetries were performed in all patients:2 patients in the sitting position and 2 in the standing position. PVRwas measured with transabdominal ultrasonography. Also, patientswere divided into two groups according to the alpha adrenergicblocker treatment; the effect of this treatment on their uroflowmetricparameters in different positions was evaluated.Results: Maximum flow rate (Qmax) and average flow rate (Qave)were significantly higher in patients in the sitting position, butthere were no differences in other uroflowmetric parameters andPVR volume (Qmax: 15.5±5.9 mL/s vs. 13.7±5.2 mL/s, Qave:11.4±4.6 mL/s vs. 10.7± 3.9 mL/s, respectively; p < 0.05). TheQmax and Qave were significantly higher in sitting position, comparedto the standing position, in both alpha adrenergic treatmentand non-treated groups; again, there were no differences in otheruroflowmetric parameters and PVR volume.Conclusion: Qmax and Qave values were significantly higher inthe sitting position. Alpha blockers did not affect any change.

scholarly journals Evaluation of Voiding Position on Uroflowmetry Parameters and Post Void Residual Urine in Patients With Benign Prostatic Hyperplasia and Healthy Men

2020 ◽  
Vol 14 (4) ◽  
pp. 155798832093896
Author(s):  
Adel Alrabadi ◽  
Saddam Al Demour ◽  
Hammam Mansi ◽  
Sohaib AlHamss ◽  
Lujain Al Omari
Keyword(s):  
Flow Rate ◽  
Maximum Flow ◽  
Standing Position ◽  
Rank Test ◽  
Sitting Position ◽  
Prostate Hyperplasia ◽  
Healthy Men ◽  
Residual Urine ◽  
Significant Difference ◽  
Group 1

Uncertainty remains whether it is best for men to void in a sitting or standing position. The objective of this study is to evaluate the effect of standing and sitting voiding position on uroflowmetry parameters and post void residual urine (PVRU) in patients with lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH) and healthy men. A total of 116 participants with BPH (Group 1) and 78 healthy men (Group 2) were enrolled in the study. The uroflowmetry parameters were measured in both positions. The PVRU volume was measured using transabdominal ultrasound after each voiding. Uroflowmetry parameters and PVRU were measured and compared between the two different voiding positions using Wilcoxon signed rank test. In Group 1, there were significant statistical differences in uroflowmetry parameters between standing and sitting voiding position. The median of maximum flow rate in Group 1 in standing and sitting position was 14.7 ml/s (IQR; 11.7–17.5) and 11 ml/s (IQR; 8.9–13.3), respectively ( p < .0001). The median voided volume at standing position was 340 ml (IQR; 276–455) while it was 267 ml (IQR; 194–390) at sitting position ( p < .0001). Median average flow rate in standing position was 5.9 ml/s (IQR; 4.5–7.5) and 5 ml (IQR; 3.2–6.4) in sitting position. There was a statistically significant difference between the median of PVRU in standing and sitting position ( p < .0001). In patients with BPH, voiding in standing position showed better uroflowmetry parameters and significant less PVRU volume.

scholarly journals Surveying the Prevalence of Lower Urinary Tract Symptoms Based on Individual and Clinical Parameters in Patients with Multiple Sclerosis

2019 ◽  
Author(s):  
Fatemeh Nazari ◽  
Vahid Shaygannejad ◽  
Mehrdad Mohammadi Sichani ◽  
Marjan Mansourian Gharaagozlou ◽  
Valiollah Hajhashemi
Keyword(s):  
Multiple Sclerosis ◽  
Urinary Tract ◽  
Symptom Score ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Statistical Tests ◽  
Men And Women ◽  
Urinary Tract Symptoms ◽  
Significant Difference ◽  
Lower Urinary

Abstract Background Most patients with multiple sclerosis (MS) suffer from bladder dysfunction during the course of the disease. This study was conducted to examine the prevalence of these complications among patients with MS. Methods This cross-sectional study was performed on 603 patients with MS who referred to the neurology clinics of Kashani and Alzahra Hospitals affiliated to Isfahan University of Medical Sciences, Isfahan, Iran. The sampling was performed by multi-stage random cluster sampling method and the informed consent form was filled in by the subjects. Then, all the data were collected through interviews using the Lower Urinary Tract Symptom Score (LUTSS) developed in accordance with the definitions presented by the International Continence Society (ICS) and the International Prostate Symptom Score (I-PSS). The data were analyzed using descriptive and inferential statistical tests in SPSS and the significance level was considered to be less than 0.050. Results The prevalence rate of lower urinary tract symptoms (LUTS) was 87.6% among all the subjects, with a similar rate among women (88.0%) and men (86.0%). There was a significant difference between the two groups of men and women in terms of the prevalence of stress urinary incontinence (SUI), intermittent urine flow, hesitancy, straining, and dribbling (P < 0.050). There was no significant difference between the two groups of women and men in terms of the prevalence of other symptoms (P > 0.050). Moreover, there was a significant difference between the degree of LUTS with age, marital status, education, duration of illness, clinical course, and disability (P < 0.05). Conclusions A high prevalence of LUTS was found among patients with MS, with similar rates in men and women, and the nature of the urinary complaints and LUTS was different among men and women with MS. Therefore, it is recommended that the health system take necessary measures regarding timely detection and treatment of LUTS among these patients in order to prevent secondary outcomes and improve the quality of life (QOL) of patients with MS.

scholarly journals Prospective randomized controlled study directly comparing tadalafil and tamsulosin for male patients with lower urinary tract symptoms

2018 ◽  
Author(s):  
Takumi Takeuchi ◽  
Satoshi Toyokawa ◽  
Yumiko Okuno ◽  
Noriko Ishida ◽  
Masanari Yamagoe ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Urine Volume ◽  
Maximum Flow ◽  
Controlled Study ◽  
Night Time ◽  
Once Daily ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

AbstractLower urinary tract symptoms are widespread in elderly men and often suggestive of benign prostatic hyperplasia (LUTS/BPH). A randomized, prospective, and open-labeled trial directly comparing the effects of tadalafil (a phosphodiesterase 5 inhibitor) 5 mg once daily and tamsulosin (an α1-blocker) 0.2 mg once daily for 12 weeks in LUTS/BPH patients was conducted. Data were recorded before randomization as well as at 4, 8, and 12 weeks after medication. Fifteen patients allocated tadalafil and 20 allocated tamsulosin completed 12 weeks of medication. Total IPSS, IPSS voiding, and IPSS-QOL scores declined with medication, but there was no difference between drugs. IPSS storage scores reduced more in the tamsulosin group than tadalafil group. OABSS did not decline significantly with medication. IIEF5 was maintained in the tadalafil group, but declined in the tamsulosin group. The maximum flow rate and post-void residual urine volume did not significantly change with medication. Daytime, night-time, and 24-hour urinary frequencies as well as the mean and largest daytime, night-time, and 24-hour voiding volumes per void did not significantly change with medication. In conclusion, tamsulosin was more effective to reduce storage symptoms than tadalafil. Tadalafil had the advantage of maintaining the erectile function.

Sign in / Sign up

Export Citation Format

Share Document